Plain-English translation of NCT06934018 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether the size of the margin—the healthy tissue around a tumor that surgeons remove during liver surgery—affects how well people with colorectal cancer that has spread to the liver do after treatment. Researchers will compare two groups: patients who receive surgery with a wider margin (at least 7 millimeters of healthy tissue) versus patients who receive surgery with a narrower margin (less than 7 millimeters). The goal is to see which approach helps prevent the cancer from coming back and improves long-term survival.
When colorectal cancer spreads to the liver, surgery is often an important treatment option. Doctors currently disagree about how much healthy tissue should be removed around the tumor to best prevent recurrence, so this trial aims to answer that question with solid evidence.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will have liver surgery to remove the tumors, and you'll be randomly assigned to one of two groups that differ only in how much healthy tissue your surgeon removes around the tumors. After your surgery, you will have regular follow-up visits and imaging tests (like CT or MRI scans) to check if the cancer comes back and to monitor your overall health. The study will track you for at least one year and longer to compare how the two margin widths affect your recovery and survival.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
China